Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ectopic Corticotropin Syndrome”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT05307328
What this trial is testing

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Who this might be right for
Cushing's Syndrome ICushing Disease Due to Increased ACTH SecretionCortisol Excess+3 more
Sparrow Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT01371565
What this trial is testing

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's DiseaseCushing's Syndrome
Corcept Therapeutics 4
Large-scale testing (Phase 3)Study completedNCT03697109
What this trial is testing

The Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

Who this might be right for
Cushing Syndrome
Corcept Therapeutics 152
Testing effectiveness (Phase 2)WithdrawnNCT02780882
What this trial is testing

SOM230 Ectopic ACTH-producing Tumors

Who this might be right for
Ectopic ACTH Syndrome
Cedars-Sinai Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00422201
What this trial is testing

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

Who this might be right for
Cushing's Syndrome
HRA Pharma 18
Testing effectiveness (Phase 2)Study completedNCT02468193
What this trial is testing

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Who this might be right for
Cushing's SyndromeEctopic Corticotropin SyndromeAdrenal Adenoma+3 more
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Looking for participantsNCT05804669
What this trial is testing

Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Who this might be right for
Cushing SyndromeCushing DiseaseEctopic ACTH Syndrome
Crinetics Pharmaceuticals Inc. 18
Large-scale testing (Phase 3)Study completedNCT04308590
What this trial is testing

The Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas

Who this might be right for
Hypercortisolism
Corcept Therapeutics 137
Not applicableEnded earlyNCT00796783
What this trial is testing

Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 2
Large-scale testing (Phase 3)Study completedNCT00936741
What this trial is testing

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 30